CN102716309A - Externally dressed drug for treating fracture - Google Patents
Externally dressed drug for treating fracture Download PDFInfo
- Publication number
- CN102716309A CN102716309A CN2011101651222A CN201110165122A CN102716309A CN 102716309 A CN102716309 A CN 102716309A CN 2011101651222 A CN2011101651222 A CN 2011101651222A CN 201110165122 A CN201110165122 A CN 201110165122A CN 102716309 A CN102716309 A CN 102716309A
- Authority
- CN
- China
- Prior art keywords
- parts
- weight parts
- fracture
- medicament
- grams
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention, relating to the field of traditional Chinese medicine, discloses an externally dressed drug for treating fracture, solving the problems of bad curative effects, slow effect and the like in the prior art by combining modern pharmacological studies based on pathologic knowledge of fracture in traditional Chinese medicine. The drug comprises the following ingredients: 20-60 weight parts of eupolyphaga sinensis, 5-25 weight parts of dragon's blood, 15-40 weight parts of cassia twig, 15-25 weight parts of olibanum, 10-20 weight parts of rhizoma anemarrhenae, 5-15 weight parts of rhizoma corydalis, 10-20 weight parts of myrrh, 5-15 weight parts of cinnabar, 10-30 weight parts of achyranthes bidentata, 5-20 weight parts of pillis ophidiae, and 20-50 weight parts of Panax notoginseng powder. The drug of the invention is used for fracture and bone lesions. After fracture patients use the drug, the wound heals quickly without recurrence, the swelling is reduced quickly, and the pain is alleviated. After the fractures are healed, there is no side effect, and limbs can move normally.
Description
Technical field:
The present invention relates to the field of Chinese medicines, be specially a kind of topical agent of treating fracture.
Background technology:
Fracture is a kind of common outer causing property damage, generally by due to the external force, is disease more serious in the traumatology.In case after fracturing, can cause whole body or local pain, redness, fracture site deforms or ruptures, walking and generation in life difficulty.
At present, doctor trained in Western medicine generally adopts after the reduction, and with clamping plate or external plaster fixation and be aided with necessary interior medicine for external use, the patient suffering is big, and healing is slow.The prescription of treatment fracture is a lot, but all has many shortcomings:
1, healing time is long;
2, take effect slowly;
3, effect is undesirable, and patient's time that groans is long.
Facts have proved that motherland's medicine and pharmacology are accumulating rich experience aspect the treatment fractures, the traditional Chinese medical science is more stressed whole treatment, and treating both the principal and secondary aspects of a disease puts prevention first, and Chinese medicine is few and celebrated with untoward reaction.Therefore, this sick Chinese medicine preparation of development treatment is highly significant with necessity.
Summary of the invention:
The object of the present invention is to provide a kind of topical agent of treating fracture, based on the pathology understanding of motherland's medical science to fracture, combine modern pharmacology research, the curative effect that exists in the solution prior art is poor, take effect and wait problem slowly.
To achieve these goals, the present invention adopts following technical scheme:
A kind of topical agent of treating fracture is counted by weight, and medicament consists of: 20～60 parts of Eupolyphaga Seu Steleophagas, 5～25 parts of Sanguis Draxonis; 15～40 parts of Ramulus Cinnamomi, 15～25 parts of Olibanums, 10～20 parts of the Rhizoma Anemarrhenaes; 5～15 parts of Rhizoma Corydalis, 10～20 parts of Myrrhas, 5～15 parts in Cinnabaris; 10～30 parts of Radix Achyranthis Bidentataes, 5～20 parts of Periostracum Serpentiss, 20～50 parts of Radix Notoginseng powder.
The topical agent of described treatment fracture is counted by weight, and the medicament composition is preferably 20～40 parts of Eupolyphaga Seu Steleophagas; 10～25 parts of Sanguis Draxonis, 25～35 parts of Ramulus Cinnamomi, 10～15 parts of Olibanums, 15～20 parts of the Rhizoma Anemarrhenaes; 5～10 parts of Rhizoma Corydalis, 20～25 parts of Myrrhas, 5～10 parts in Cinnabaris; 15～20 parts of Radix Achyranthis Bidentataes, 10～15 parts of Periostracum Serpentiss, 20～35 parts of Radix Notoginseng powder.
The topical agent of described treatment fracture is counted by weight, and the medicament composition is preferably 25～30 parts of Eupolyphaga Seu Steleophagas; 12～20 parts of Sanguis Draxonis, 28～30 parts of Ramulus Cinnamomi, Olibanum 20-25 part, 15～17 parts of the Rhizoma Anemarrhenaes; 8～10 parts of Rhizoma Corydalis, 10～15 parts of Myrrhas, 10～15 parts in Cinnabaris; 19～20 parts of Radix Achyranthis Bidentataes, 8～10 parts of Periostracum Serpentiss, 30～35 parts of Radix Notoginseng powder.
The topical agent of described treatment fracture is counted by weight, and the medicament composition is preferably 30 parts of Eupolyphaga Seu Steleophagas, 15 parts of Sanguis Draxonis, 30 parts of Ramulus Cinnamomi, 15 parts of Olibanums, 15 parts of the Rhizoma Anemarrhenaes, 10 parts of Rhizoma Corydalis, 15 parts of Myrrhas, 10 parts in Cinnabaris, 20 parts of Radix Achyranthis Bidentataes, 10 parts of Periostracum Serpentiss, 30 parts of Radix Notoginseng powder.
Said medicament is Powdered, and Radix Notoginseng powder is a powdery, and granularity is about the 80-150 order, and the granularity of all the other powder is the 8-12 order.
The present invention treats the topical agent of fracture, and every secondary topical agent is got the 150-200 gram.Medicament is poured medicament in the vinegar into and to be stirred before use, and the part by weight of vinegar and medicament is 50: (150-200), pave the back with the gauze parcel then and use, spread on the wound during use and get final product; During external application, the medicine layer thickness is 0.8～1.2 centimetre, covers outer rim 3-5 centimetre at ultra injury place.
Pharmacology analysis of the present invention is following:
(1) Eupolyphaga Seu Steleophaga has anticoagulation and to Fibrinolytic effect, experiment shows: Eupolyphaga Seu Steleophaga has blood coagulation resisting function, can improve and strengthen the blood supply of major organs, tissue and whole body in the body; The Eupolyphaga Seu Steleophaga water extract is given rat oral gavage, and continuous 7 days, ability is prolong rats bleeding time and recalcification time obviously; Hematoblastic PAR there is remarkable inhibitory action, has removing blood stasis with potent drugs blood, the effect of reuniting the fractured tendons and bones; Be used for the muscles and bones folding and hinder blood stasis amenorrhea, miasma abdominal mass mass in the abdomen.
(2) Sanguis Draxonis has the effect of promoting blood circulation to remove blood stasis, analgesic therapy, hemostasia and promoting granulation, and zoopery proves that Sanguis Draxonis can significantly shorten the plasma in rabbit recalcification time, thereby increases its Blood clotting." Haiyao Bencao, Oversea Materia Medica " record: Sanguis Draxonis is leading traumatics fracture damage, and tonify deficiency and vim and vigour are stirred thorn, and interior blood trouble is gathered.
(3) Ramulus Cinnamomi has blood vessel dilating, regulates blood circulation, makes blood flow to body surface, reinforcement Herba Ephedrae perspiration." book on Chinese herbal medicine converge with speech " record, Ramulus Cinnamomi is dispersing wind and cold, by pathogenic factor in the exterior, sends out antiperspirant evil, removes the medicine of wind pain between podomere.Though it is hot that abnormal smells from the patient does not leave, body belongs to branch, only can disperse between the fur flesh natural fibre line of meat parade arm knee joint podomere part.
(4) Olibanum is used to treat regulating qi and activating blood, controls coagulation of QI-blood, trusted subordinate's pain, carbuncle pyogenic infections from tumour or sore, traumatic injury." book on Chinese herbal medicine converges and says " record: the wind of invigorating blood circulation, the medicine of muscles and tendons relaxing to alleviate pain, falling again beats beats, folding muscle and tendon injury bone.
(5) Rhizoma Anemarrhenae belongs to gunpowder under the heat clearing away, cures mainly: epidemic febrile disease, hyperpyrexia excessive thirst, cough and asthma, cough caused by dryness, constipation, osteopyrexia and fever, restlessness of asrhenia type and insomnia, the stranguria with turbid discharge of quenching one's thirst.
(6) Rhizoma Corydalis is regulated the flow of vital energy, is invigorated blood circulation, pain relieving, has the hemostasis heat-clearing and toxic substances removing, and the effect of promoting blood circulation and stopping pain is applicable to the light disease of furuncle and phyma.
(7) Myrrha cures mainly breast abdomen stasis of blood pain, dysmenorrhea, amenorrhea, lump in the abdomen, traumatic injury, carbuncle skin infection, acute appendicitis, conjunctival congestion and swelling pain.Effects such as promoting blood circulation and stopping pain, detumescence and promoting granulation are arranged." Bencao Jingshu " record: the Myrrha bitter in the mouth is flat nontoxic, and right putting down should be made suffering, and gas should be slightly cold.All malignant boil anal fistula all forms because of the heat in blood stasis of blood stagnates, and receives Jin Ren and flogging trauma to make skin ulcer outward, and also all flesh and blood receives disease.Flesh and blood is hindered then the stasis of blood and is generated heat and have a pain, and this medicine hardship can be let out, hot can loosing, the ability of trembling with fear heat extraction.Water belongs to cloudy, and blood also belongs to the moon, with class from, so can go into blood system, dissipating blood stasis blood, control all skin ulcers of heat in blood and soldier right under blood disorder also.
(8) Cinnabaris, it is relieving convulsion to be used to clear away heart-fire, the detoxifcation of calming the nerves." book on Chinese herbal medicine just " record: Cinnabaris is gone into the heart and can be calmed the nerves and walk blood vessels, and going into lung can sending down the abnormal ascending QI and walk fur, goes into spleen and can and walk muscle by sputum, goes into the feasible stasis of liver and walks fascia, goes into kidney and can relieve oedema or abdominal distension through diuresis or purgation heresy and walk bone marrow.
(9) Radix Achyranthis Bidentatae is used for bone and muscle strengthening, promoting blood circulation to restore menstrual flow." the southern regions of the Yunnan Province book on Chinese herbal medicine " record: Radix Achyranthis Bidentatae ends muscles and bones aching, strong muscle Shujin, and it is tingle to end the waist knee joint.
(10) Periostracum Serpentis is used to dispel the wind, calms the frightened, detoxifcation, nebula removing.
(11) Radix Notoginseng powder has effects such as hemostasis, blood circulation promoting and blood stasis dispelling, subduing swelling and relieving pain, strengthening by means of tonics, resisting fatigue, anoxia enduring, defying age, blood fat reducing, blood sugar lowering, human body immunity improving function.
Beneficial effect of the present invention:
1, the present invention is used for treatment fracture and bone damage, and fracture patient is after using topical agent of the present invention, and speed of wound healing is fast, is difficult for recurrence;
2, after the use, swelling place of wound can be subsided a swelling rapidly, has reduced patient's misery;
3, after the fracture healing, have no side effect, limbs can be as freedom of movement before sick.
The specific embodiment:
Among the present invention, medicament is Powdered, and Radix Notoginseng powder is a powdery, and granularity is about the 80-150 order, and the granularity of all the other powder is the 8-12 order.Every secondary topical agent is got the 150-200 gram.Medicament is poured medicament in the vinegar into and to be stirred before use, and the part by weight of vinegar and medicament is 50: (150-200), pave the back with the gauze parcel then and use, spread on the wound during use and get final product; During external application, the medicine layer thickness is 0.8～1.2 centimetre, covers outer rim 3-5 centimetre at ultra injury place.
Embodiment 1
In the present embodiment, the consisting of of medicament: Eupolyphaga Seu Steleophaga 30 grams, Sanguis Draxonis 15 grams, Ramulus Cinnamomi 30 grams, Olibanum 20 grams, the Rhizoma Anemarrhenae 15 grams, Rhizoma Corydalis 10 grams, Myrrha 10 grams, Cinnabaris 10 grams, Radix Achyranthis Bidentatae 20 grams, 8 parts of Periostracum Serpentiss, Radix Notoginseng powder 30 grams; Before the use, the medicament powder poured in 50 milliliters of vinegars stir, use with gauze parcel back then, spread on during use on the wound (swelling place or bone splits place), during external application, the medicine layer thickness is 1 centimetre, covers outer rim 3-5 centimetre at ultra injury place.
Clinical instance:
Ten thousand so-and-so, woman, 45 years old, community work personnel; Fall during skating and cause thoracic vertebra 11,12 compression fracturees, can only lie in bed; Use the embodiment of the invention 1 external application for curing, changed once in 7 days, i.e. healing in 20 days can be walked after 23 days with descending, recovered normal after 30 days.
Embodiment 2
In the present embodiment, the consisting of of medicament: Eupolyphaga Seu Steleophaga 20 grams, Sanguis Draxonis 25 grams, Ramulus Cinnamomi 30 grams, Olibanum 15 grams, the Rhizoma Anemarrhenae 10 grams, Rhizoma Corydalis 15 grams, Myrrha 15 grams, Cinnabaris 5 grams, Radix Achyranthis Bidentatae 20 grams, 5 parts of Periostracum Serpentiss, Radix Notoginseng powder 30 grams; Before the use, the medicament powder poured in 50 milliliters of vinegars stir, use with gauze parcel back then, spread on during use on the wound (swelling place or bone splits place), during external application, the medicine layer thickness is 1 centimetre, covers outer rim 3-5 centimetre at ultra injury place.
Clinical instance:
Lin, woman, 36 years old, certain engineer of coal research branch; In the time of downstairs, do not stand firm, cause the fracture of tarsus of foot, swelling can not be walked, and action is obstructed; Use the embodiment of the invention 2 external application for curing, changed once in 7 days, i.e. healing in 15 days can be walked after 20 days with descending, recovered normal after 23 days.
Embodiment 3
In the present embodiment, the consisting of of medicament: Eupolyphaga Seu Steleophaga 60 grams, Sanguis Draxonis 5 grams, Ramulus Cinnamomi 15 grams, Olibanum 25 grams, the Rhizoma Anemarrhenae 15 grams, Rhizoma Corydalis 10 grams, Myrrha 10 grams, Cinnabaris 10 grams, Radix Achyranthis Bidentatae 10 grams, 5 parts of Periostracum Serpentiss, Radix Notoginseng powder 35 grams; Before the use, the medicament powder poured in 50 milliliters of vinegars stir, use with gauze parcel back then, spread on during use on the wound (swelling place or bone splits place), during external application, the medicine layer thickness is 1 centimetre, covers outer rim 3-5 centimetre at ultra injury place.
Clinical instance:
Zhang, man 42 years old, carpenter; Jump off from the about 2 meters scaffold of height during work, cause sufficient root bone fracture, swelling can not be walked; Use the embodiment of the invention 3 external application for curing, changed once in 7 days, i.e. healing in 17 days can be walked after 20 days with descending, recovered normal after 25 days.
Embodiment 4
In the present embodiment, the consisting of of medicament: Eupolyphaga Seu Steleophaga 30 grams, Sanguis Draxonis 10 grams, Ramulus Cinnamomi 40 grams, Olibanum 15 grams, the Rhizoma Anemarrhenae 20 grams, Rhizoma Corydalis 5 grams, Myrrha 10 grams, Cinnabaris 5 grams, Radix Achyranthis Bidentatae 25 grams, 5 parts of Periostracum Serpentiss, Radix Notoginseng powder 20 grams; Before the use, the medicament powder poured in 50 milliliters of vinegars stir, use with gauze parcel back then, spread on during use on the wound (swelling place or bone splits place), during external application, the medicine layer thickness is 1 centimetre, covers outer rim 3-5 centimetre at ultra injury place.
Embodiment 5
In the present embodiment, the consisting of of medicament: Eupolyphaga Seu Steleophaga 30 grams, Sanguis Draxonis 15 grams, Ramulus Cinnamomi 30 grams, Olibanum 15 grams, the Rhizoma Anemarrhenae 15 grams, Rhizoma Corydalis 10 grams, Myrrha 15 grams, Cinnabaris 10 grams, Radix Achyranthis Bidentatae 20 grams, Periostracum Serpentis 10 grams, Radix Notoginseng powder 30 grams; Before the use, the medicament powder poured in 50 milliliters of vinegars stir, use with gauze parcel back then, spread on during use on the wound (swelling place or bone splits place), during external application, the medicine layer thickness is 1 centimetre, covers outer rim 3-5 centimetre at ultra injury place.
Clinical instance:
Ten thousand so-and-so, the man, 31 years old, the driver, weight is slipped to instep during unloading, and big toe is pounded into comminuted fracture, and is agonizing, swelling can't be walked; Use the embodiment of the invention 4 external application for curing, changed once in 7 days, i.e. healing in 19 days can be walked after 20 days with descending, recovered normal after 25 days.
Claims (6)
1. a topical agent of treating fracture is characterized in that, counts by weight, and medicament consists of: 20～60 parts of Eupolyphaga Seu Steleophagas; 5～25 parts of Sanguis Draxonis, 15～40 parts of Ramulus Cinnamomi, 15～25 parts of Olibanums, 10～20 parts of the Rhizoma Anemarrhenaes; 5～15 parts of Rhizoma Corydalis, 10～20 parts of Myrrhas, 5～15 parts in Cinnabaris; 10～30 parts of Radix Achyranthis Bidentataes, 5～20 parts of Periostracum Serpentiss, 20～50 parts of Radix Notoginseng powder.
2. according to the topical agent of the described treatment fracture of claim 1, it is characterized in that, count by weight that the medicament composition is preferably; 20～40 parts of Eupolyphaga Seu Steleophagas, 10～25 parts of Sanguis Draxonis, 25～35 parts of Ramulus Cinnamomi, 10～15 parts of Olibanums; 15～20 parts of the Rhizoma Anemarrhenaes, 5～10 parts of Rhizoma Corydalis, 20～25 parts of Myrrhas, 5～10 parts in Cinnabaris; 15～20 parts of Radix Achyranthis Bidentataes, 10～15 parts of Periostracum Serpentiss, 20～35 parts of Radix Notoginseng powder.
3. according to the topical agent of the described treatment fracture of claim 1, it is characterized in that, count by weight that the medicament composition is preferably; 25～30 parts of Eupolyphaga Seu Steleophagas, 12～20 parts of Sanguis Draxonis, 28～30 parts of Ramulus Cinnamomi, Olibanum 20-25 part; 15～17 parts of the Rhizoma Anemarrhenaes, 8～10 parts of Rhizoma Corydalis, 10～15 parts of Myrrhas, 10～15 parts in Cinnabaris; 19～20 parts of Radix Achyranthis Bidentataes, 8～10 parts of Periostracum Serpentiss, 30～35 parts of Radix Notoginseng powder.
4. according to the topical agent of the described treatment fracture of claim 1, it is characterized in that, count by weight that the medicament composition is preferably; 30 parts of Eupolyphaga Seu Steleophagas, 15 parts of Sanguis Draxonis, 30 parts of Ramulus Cinnamomi, 15 parts of Olibanums; 15 parts of the Rhizoma Anemarrhenaes, 10 parts of Rhizoma Corydalis, 15 parts of Myrrhas, 10 parts in Cinnabaris; 20 parts of Radix Achyranthis Bidentataes, 10 parts of Periostracum Serpentiss, 30 parts of Radix Notoginseng powder.
5. according to the topical agent of the described treatment fracture of claim 1, it is characterized in that medicament is Powdered, Radix Notoginseng powder is a powdery, and granularity is about the 80-150 order, and the granularity of all the other powder is the 8-12 order.
6. according to the topical agent of the described treatment fracture of claim 1, it is characterized in that every secondary topical agent is got the 150-200 gram; Medicament before use; Medicament poured in the vinegar stir, the part by weight of vinegar and medicament is 50: (150-200), use gauze parcel back then.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201110165122.2A CN102716309B (en) | 2011-06-20 | 2011-06-20 | Externally dressed drug for treating fracture |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201110165122.2A CN102716309B (en) | 2011-06-20 | 2011-06-20 | Externally dressed drug for treating fracture |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102716309A true CN102716309A (en) | 2012-10-10 |
| CN102716309B CN102716309B (en) | 2014-04-30 |
Family
ID=46942263
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201110165122.2A Expired - Fee Related CN102716309B (en) | 2011-06-20 | 2011-06-20 | Externally dressed drug for treating fracture |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102716309B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105878768A (en) * | 2014-05-06 | 2016-08-24 | 陈子银 | Preparation method of ointment for treating fracture and rheumatism involving bone |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1342488A (en) * | 2001-09-30 | 2002-04-03 | 吴绍静 | Chinese medicine preparation 'Jiangudan' |
| CN1520854A (en) * | 2003-02-12 | 2004-08-18 | 戬 王 | Bone fracture therapeutic pharmaceuticals |
| US20050037094A1 (en) * | 2003-07-31 | 2005-02-17 | Xijun Yan | Composition for heart disease, its active ingredients, method to prepare same and uses thereof |
| CN1899598A (en) * | 2006-07-19 | 2007-01-24 | 李永胜 | Combined medicine for preventing and treating rheumatism, rheumatoid, protrusion of intervertebral disc and hyperosteogeny |
| CN101428121A (en) * | 2007-11-06 | 2009-05-13 | 赵淑珍 | Traditional Chinese medicine liniment for activating blood circulation and removing stasis, dispersing the swelling, relieving pain, relaxing tendons and activating collaterals |
| CN101966316A (en) * | 2009-07-28 | 2011-02-09 | 上海佰加壹医药有限公司 | Gujin pill pellet and preparation method thereof |
-
2011
- 2011-06-20 CN CN201110165122.2A patent/CN102716309B/en not_active Expired - Fee Related
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1342488A (en) * | 2001-09-30 | 2002-04-03 | 吴绍静 | Chinese medicine preparation 'Jiangudan' |
| CN1520854A (en) * | 2003-02-12 | 2004-08-18 | 戬 王 | Bone fracture therapeutic pharmaceuticals |
| US20050037094A1 (en) * | 2003-07-31 | 2005-02-17 | Xijun Yan | Composition for heart disease, its active ingredients, method to prepare same and uses thereof |
| CN1899598A (en) * | 2006-07-19 | 2007-01-24 | 李永胜 | Combined medicine for preventing and treating rheumatism, rheumatoid, protrusion of intervertebral disc and hyperosteogeny |
| CN101428121A (en) * | 2007-11-06 | 2009-05-13 | 赵淑珍 | Traditional Chinese medicine liniment for activating blood circulation and removing stasis, dispersing the swelling, relieving pain, relaxing tendons and activating collaterals |
| CN101966316A (en) * | 2009-07-28 | 2011-02-09 | 上海佰加壹医药有限公司 | Gujin pill pellet and preparation method thereof |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105878768A (en) * | 2014-05-06 | 2016-08-24 | 陈子银 | Preparation method of ointment for treating fracture and rheumatism involving bone |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102716309B (en) | 2014-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102091202B (en) | Traditional Chinese medicinal composition for treating fracture and preparation method thereof | |
| CN102988657B (en) | Plaster for treating fracture and traumatic injury and preparation method of plaster | |
| CN102309644A (en) | Traditional Chinese medical composition for treating bone fracture | |
| CN1839941A (en) | Chinese prepared medicine for treating bone pain | |
| CN102895460B (en) | Traditional Chinese medicine composition for fracture and soft tissue injury | |
| CN103263551A (en) | Powder for external use for relieving swelling and dispersing blood stasis | |
| CN103055260A (en) | Traditional Chinese medicine composition for treating ulcerative colitis and preparation method thereof | |
| CN102228586B (en) | Ointment for promoting union of bone fractures and preparation method thereof | |
| CN102836307A (en) | Chinese herbal medicine formula for treating traumatic injuries, tendon injuries and fractures | |
| CN101322786B (en) | External-use medicament for treating bone fracture and traumatic injury | |
| CN104784639B (en) | Repair the Chinese medicine composition, preparation, preparation method and application of cartilage tissue damage | |
| CN103768531A (en) | Traditional Chinese medicinal composition for treating rheumatoid arthritis and preparation method thereof | |
| CN103027978A (en) | Medicine composition for treating traumatic injury and preparation method of medicine composition | |
| CN103156992A (en) | An external application plaster combination for treatment of fracture injuries and a preparation method thereof | |
| CN102451331A (en) | Traditional Chinese preparation for treating barrenness | |
| CN102716309B (en) | Externally dressed drug for treating fracture | |
| CN101732667B (en) | Traditional Chinese medicine for eliminating blood stasis and smoothing collaterals | |
| CN103623350A (en) | Traditional Chinese medicine plaster with effect of boosting fracture healing | |
| CN102579605A (en) | Oral Chinese medicinal composition for treating bone fracture diseases | |
| CN103417788B (en) | One treats fracture Chinese medicine for oral administration | |
| CN106236964A (en) | A kind of Chinese medicine treating joint disease | |
| CN102145099A (en) | Traditional Chinese medicine for treating infertility caused by liver stagnation | |
| CN101259200B (en) | Orally-administered and externally-applied specific medicine for treating bone injury disease, protrusion of lumbar intervertebral discs and wrick | |
| CN104800443A (en) | Bone setting agent with functions of tonifying kidney and regenerating bone marrow | |
| CN102205006A (en) | External medicament for treating osteomyelitis and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140430 Termination date: 20180620 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |